Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
Type 2 diabetes is a progressive condition in which the body becomes resistant to the normal effects of insulin and/or gradually loses the capacity to produce enough insulin in the pancreas. We do not know what causes type 2 diabetes. Type 2 diabetes is associated with modifiable lifestyle risk factors. Type 2 diabetes also has strong genetic and family related risk factors.
The dramatic increase in the prevalence, progressive nature and diagnosis of type 2 diabetes is the main driver of this rapid growth rate. The rise in disease-related comorbidities has also fuelled a more aggressive approach to treatment, including the use of multiple-drug therapies.The Americas dominated the global type 1 diabetes drug market and accounted for close to 50% of the global type 1 diabetes market size. The US was the largest revenue contributor to the diabetes drug market in this region because of the growing prevalence of the disease and rise in obesity. The accessibility to therapies by reimbursement programs is further expected to drive the growth of the diabetes drug market size in the Americas.
Type 2 Diabetes market report explains the definition, types, applications, major countries, and major players of the Type 2 Diabetes market. The report mainly contains different types, applications, and regional historical data from 2017-2021 and forecast data from 2022-2028.
The report contains qualitative and quantitative analysis of the entire industry.
The influence of COVID-19 has been considered in the report. Coronavirus Impact is included in Chapter 2. In addition, Strategic Analytics to Boost Productivity and Profitability is included in Chapter 3.
By Player:
AstraZeneca
Daiichi Sankyo
Sanofi
Eli Lily
Merck
Biocon
Novo Nordisk
Boehringer Ingelheim
Astellas Pharma
By Type:
Insulins
DPP-4 Inhibitors
GLP-1 Receptor Agonists
SGLT-2 Inhibitors
By End-User:
Drugstore
Hospital
Others
By Region:
North America
-
United States
-
Canada
-
Mexico
Europe
-
Germany
-
UK
-
Spain
-
France
-
Italy
-
Denmark
-
Finland
-
Norway
-
Sweden
-
Poland
-
Russia
-
Turkey
Asia-Pacific
-
China
-
Japan
-
India
-
South Korea
-
Pakistan
-
Bangladesh
-
Indonesia
-
Thailand
-
Singapore
-
Malaysia
-
Philippines
-
Vietnam
-
Others
South America
-
Brazil
-
Colombia
-
Chile
-
Argentina
-
Venezuela
-
Peru
-
Puerto Rico
-
Ecuador
-
Others
GCC
-
Bahrain
-
Kuwait
-
Oman
-
Qatar
-
Saudi Arabia
-
United Arab Emirates
Africa
-
Nigeria
-
South Africa
-
Egypt
-
Algeriat
-
Others
Oceania
-
Australia
-
New Zealand
TABLE OF CONTENT
1. Global Type 2 Diabetes Executive Summary
-
1.1 Introduction
-
1.2 Market Panorama, 2022
2 Coronavirus Impact
-
2.1 Type 2 Diabetes Outlook to 2028- Original Forecasts
-
2.2 Type 2 Diabetes Outlook to 2028- COVID-19 Affected Forecasts
-
2.3 Impact on Industry
3 Strategic Analytics to Boost Productivity and Profitability
-
3.1 Potential Market Drivers and Opportunities
-
3.2 New Challenges and Strategies
-
3.3 Short Term and Long Term Type 2 Diabetes Market Trends
4 Key Inferences
5 Market Overview
-
5.1 Current Market Scenario
-
5.2 Porter's Five Forces Analysis
-
5.2.1 Bargaining Power of Suppliers
-
5.2.2 Bargaining Power of Consumers
-
5.2.3 Threat of New Entrants
-
5.2.4 Threat of Substitute Product and Services
-
5.2.5 Competitive Rivalry within the Industry
6 Global Type 2 Diabetes Market- Recent Developments
-
6.1 Type 2 Diabetes Market News and Developments
-
6.2 Type 2 Diabetes Market Deals Landscape
7 Type 2 Diabetes Raw Materials and Cost Structure Analysis
-
7.1 Type 2 Diabetes Key Raw Materials
-
7.2 Type 2 Diabetes Price Trend of Key Raw Materials
-
7.3 Type 2 Diabetes Key Suppliers of Raw Materials
-
7.4 Type 2 Diabetes Market Concentration Rate of Raw Materials
-
7.5 Type 2 Diabetes Cost Structure Analysis
-
7.5.1 Type 2 Diabetes Raw Materials Analysis
-
7.5.2 Type 2 Diabetes Labor Cost Analysis
-
7.5.3 Type 2 Diabetes Manufacturing Expenses Analysis
8 Global Type 2 Diabetes Import and Export Analysis (Top 10 Countries)
-
8.1 Global Type 2 Diabetes Import by Region (Top 10 Countries) (2017-2028)
-
8.2 Global Type 2 Diabetes Export by Region (Top 10 Countries) (2017-2028)
9 Global Type 2 Diabetes Market Outlook by Types and Applications to 2022
-
9.1 Global Type 2 Diabetes Consumption and Growth Rate by Type (2017-2022)
-
9.1.1 Global Insulins Consumption and Growth Rate (2017-2022)
-
9.1.2 Global DPP-4 Inhibitors Consumption and Growth Rate (2017-2022)
-
9.1.3 Global GLP-1 Receptor Agonists Consumption and Growth Rate (2017-2022)
-
9.1.4 Global SGLT-2 Inhibitors Consumption and Growth Rate (2017-2022)
-
9.2 Global Type 2 Diabetes Consumption and Growth Rate by Application (2017-2022)
-
9.2.1 Global Drugstore Consumption and Growth Rate (2017-2022)
-
9.2.2 Global Hospital Consumption and Growth Rate (2017-2022)
-
9.2.3 Global Others Consumption and Growth Rate (2017-2022)
10 Region and Country-wise Type 2 Diabetes Market Analysis and Outlook till 2022
-
10.1 Global Type 2 Diabetes Consumption (2017-2022)
-
10.2 North America Consumption Analysis
-
10.2.1 United States Type 2 Diabetes Consumption (2017-2022)
-
10.2.2 Canada Type 2 Diabetes Consumption (2017-2022)
-
10.2.3 Mexico Type 2 Diabetes Consumption (2017-2022)
-
10.3 Europe Consumption Analysis
-
10.3.1 Germany Type 2 Diabetes Consumption (2017-2022)
-
10.3.2 UK Type 2 Diabetes Consumption (2017-2022)
-
10.3.3 Spain Type 2 Diabetes Consumption (2017-2022)
-
10.3.4 Belgium Type 2 Diabetes Consumption (2017-2022)
-
10.3.5 France Type 2 Diabetes Consumption (2017-2022)
-
10.3.6 Italy Type 2 Diabetes Consumption (2017-2022)
-
10.3.7 Denmark Type 2 Diabetes Consumption (2017-2022)
-
10.3.8 Finland Type 2 Diabetes Consumption (2017-2022)
-
10.3.9 Norway Type 2 Diabetes Consumption (2017-2022)
-
10.3.10 Sweden Type 2 Diabetes Consumption (2017-2022)
-
10.3.11 Poland Type 2 Diabetes Consumption (2017-2022)
-
10.3.12 Russia Type 2 Diabetes Consumption (2017-2022)
-
10.3.13 Turkey Type 2 Diabetes Consumption (2017-2022)
-
10.4 APAC Consumption Analysis
-
10.4.1 China Type 2 Diabetes Consumption (2017-2022)
-
10.4.2 Japan Type 2 Diabetes Consumption (2017-2022)
-
10.4.3 India Type 2 Diabetes Consumption (2017-2022)
-
10.4.4 South Korea Type 2 Diabetes Consumption (2017-2022)
-
10.4.5 Pakistan Type 2 Diabetes Consumption (2017-2022)
-
10.4.6 Bangladesh Type 2 Diabetes Consumption (2017-2022)
-
10.4.7 Indonesia Type 2 Diabetes Consumption (2017-2022)
-
10.4.8 Thailand Type 2 Diabetes Consumption (2017-2022)
-
10.4.9 Singapore Type 2 Diabetes Consumption (2017-2022)
-
10.4.10 Malaysia Type 2 Diabetes Consumption (2017-2022)
-
10.4.11 Philippines Type 2 Diabetes Consumption (2017-2022)
-
10.4.12 Vietnam Type 2 Diabetes Consumption (2017-2022)
-
10.5 South America Consumption Analysis
-
10.5.1 Brazil Type 2 Diabetes Consumption (2017-2022)
-
10.5.2 Colombia Type 2 Diabetes Consumption (2017-2022)
-
10.5.3 Chile Type 2 Diabetes Consumption (2017-2022)
-
10.5.4 Argentina Type 2 Diabetes Consumption (2017-2022)
-
10.5.5 Venezuela Type 2 Diabetes Consumption (2017-2022)
-
10.5.6 Peru Type 2 Diabetes Consumption (2017-2022)
-
10.5.7 Puerto Rico Type 2 Diabetes Consumption (2017-2022)
-
10.5.8 Ecuador Type 2 Diabetes Consumption (2017-2022)
-
10.6 GCC Consumption Analysis
-
10.6.1 Bahrain Type 2 Diabetes Consumption (2017-2022)
-
10.6.2 Kuwait Type 2 Diabetes Consumption (2017-2022)
-
10.6.3 Oman Type 2 Diabetes Consumption (2017-2022)
-
10.6.4 Qatar Type 2 Diabetes Consumption (2017-2022)
-
10.6.5 Saudi Arabia Type 2 Diabetes Consumption (2017-2022)
-
10.6.6 United Arab Emirates Type 2 Diabetes Consumption (2017-2022)
-
10.7 Africa Consumption Analysis
-
10.7.1 Nigeria Type 2 Diabetes Consumption (2017-2022)
-
10.7.2 South Africa Type 2 Diabetes Consumption (2017-2022)
-
10.7.3 Egypt Type 2 Diabetes Consumption (2017-2022)
-
10.7.4 Algeria Type 2 Diabetes Consumption (2017-2022)
-
10.8 Oceania Consumption Analysis
-
10.8.1 Australia Type 2 Diabetes Consumption (2017-2022)
-
10.8.2 New Zealand Type 2 Diabetes Consumption (2017-2022)
11 Global Type 2 Diabetes Competitive Analysis
-
11.1 AstraZeneca
-
11.1.1 AstraZeneca Company Details
-
11.1.2 AstraZeneca Type 2 Diabetes Sales, Price, Value and Gross Profit (2017-2022)
-
11.1.3 AstraZeneca Type 2 Diabetes Main Business and Markets Served
-
11.1.4 AstraZeneca Type 2 Diabetes Product Portfolio
-
11.1.5 Recent Research and Development Strategies
-
11.2 Daiichi Sankyo
-
11.2.1 Daiichi Sankyo Company Details
-
11.2.2 Daiichi Sankyo Type 2 Diabetes Sales, Price, Value and Gross Profit (2017-2022)
-
11.2.3 Daiichi Sankyo Type 2 Diabetes Main Business and Markets Served
-
11.2.4 Daiichi Sankyo Type 2 Diabetes Product Portfolio
-
11.2.5 Recent Research and Development Strategies
-
11.3 Sanofi
-
11.3.1 Sanofi Company Details
-
11.3.2 Sanofi Type 2 Diabetes Sales, Price, Value and Gross Profit (2017-2022)
-
11.3.3 Sanofi Type 2 Diabetes Main Business and Markets Served
-
11.3.4 Sanofi Type 2 Diabetes Product Portfolio
-
11.3.5 Recent Research and Development Strategies
-
11.4 Eli Lily
-
11.4.1 Eli Lily Company Details
-
11.4.2 Eli Lily Type 2 Diabetes Sales, Price, Value and Gross Profit (2017-2022)
-
11.4.3 Eli Lily Type 2 Diabetes Main Business and Markets Served
-
11.4.4 Eli Lily Type 2 Diabetes Product Portfolio
-
11.4.5 Recent Research and Development Strategies
-
11.5 Merck
-
11.5.1 Merck Company Details
-
11.5.2 Merck Type 2 Diabetes Sales, Price, Value and Gross Profit (2017-2022)
-
11.5.3 Merck Type 2 Diabetes Main Business and Markets Served
-
11.5.4 Merck Type 2 Diabetes Product Portfolio
-
11.5.5 Recent Research and Development Strategies
-
11.6 Biocon
-
11.6.1 Biocon Company Details
-
11.6.2 Biocon Type 2 Diabetes Sales, Price, Value and Gross Profit (2017-2022)
-
11.6.3 Biocon Type 2 Diabetes Main Business and Markets Served
-
11.6.4 Biocon Type 2 Diabetes Product Portfolio
-
11.6.5 Recent Research and Development Strategies
-
11.7 Novo Nordisk
-
11.7.1 Novo Nordisk Company Details
-
11.7.2 Novo Nordisk Type 2 Diabetes Sales, Price, Value and Gross Profit (2017-2022)
-
11.7.3 Novo Nordisk Type 2 Diabetes Main Business and Markets Served
-
11.7.4 Novo Nordisk Type 2 Diabetes Product Portfolio
-
11.7.5 Recent Research and Development Strategies
-
11.8 Boehringer Ingelheim
-
11.8.1 Boehringer Ingelheim Company Details
-
11.8.2 Boehringer Ingelheim Type 2 Diabetes Sales, Price, Value and Gross Profit (2017-2022)
-
11.8.3 Boehringer Ingelheim Type 2 Diabetes Main Business and Markets Served
-
11.8.4 Boehringer Ingelheim Type 2 Diabetes Product Portfolio
-
11.8.5 Recent Research and Development Strategies
-
11.9 Astellas Pharma
-
11.9.1 Astellas Pharma Company Details
-
11.9.2 Astellas Pharma Type 2 Diabetes Sales, Price, Value and Gross Profit (2017-2022)
-
11.9.3 Astellas Pharma Type 2 Diabetes Main Business and Markets Served
-
11.9.4 Astellas Pharma Type 2 Diabetes Product Portfolio
-
11.9.5 Recent Research and Development Strategies
12 Global Type 2 Diabetes Market Outlook by Types and Applications to 2028
-
12.1 Global Type 2 Diabetes Consumption Forecast and Growth Rate by Type (2022-2028)
-
12.1.1 Global Insulins Consumption Forecast and Growth Rate (2022-2028)
-
12.1.2 Global DPP-4 Inhibitors Consumption Forecast and Growth Rate (2022-2028)
-
12.1.3 Global GLP-1 Receptor Agonists Consumption Forecast and Growth Rate (2022-2028)
-
12.1.4 Global SGLT-2 Inhibitors Consumption Forecast and Growth Rate (2022-2028)
-
12.2 Global Type 2 Diabetes Consumption Forecast and Growth Rate by Application (2022-2028)
-
12.2.1 Global Drugstore Consumption Forecast and Growth Rate (2022-2028)
-
12.2.2 Global Hospital Consumption Forecast and Growth Rate (2022-2028)
-
12.2.3 Global Others Consumption Forecast and Growth Rate (2022-2028)
13 Country-wise Type 2 Diabetes Market Analysis and Outlook to 2028
-
13.1 Global Type 2 Diabetes Consumption Forecast (2022-2028)
-
13.2 North America Consumption Analysis
-
13.2.1 United States Type 2 Diabetes Consumption Forecast (2022-2028)
-
13.2.2 Canada Type 2 Diabetes Consumption Forecast (2022-2028)
-
13.2.3 Mexico Type 2 Diabetes Consumption Forecast (2022-2028)
-
13.3 Europe Consumption Analysis
-
13.3.1 Germany Type 2 Diabetes Consumption Forecast (2022-2028)
-
13.3.2 UK Type 2 Diabetes Consumption Forecast (2022-2028)
-
13.3.3 Spain Type 2 Diabetes Consumption Forecast (2022-2028)
-
13.3.4 Belgium Type 2 Diabetes Consumption Forecast (2022-2028)
-
13.3.5 France Type 2 Diabetes Consumption Forecast (2022-2028)
-
13.3.6 Italy Type 2 Diabetes Consumption Forecast (2022-2028)
-
13.3.7 Denmark Type 2 Diabetes Consumption Forecast (2022-2028)
-
13.3.8 Finland Type 2 Diabetes Consumption Forecast (2022-2028)
-
13.3.9 Norway Type 2 Diabetes Consumption Forecast (2022-2028)
-
13.3.10 Sweden Type 2 Diabetes Consumption Forecast (2022-2028)
-
13.3.11 Poland Type 2 Diabetes Consumption Forecast (2022-2028)
-
13.3.12 Russia Type 2 Diabetes Consumption Forecast (2022-2028)
-
13.3.13 Turkey Type 2 Diabetes Consumption Forecast (2022-2028)
-
13.4 APAC Consumption Analysis
-
13.4.1 China Type 2 Diabetes Consumption Forecast (2022-2028)
-
13.4.2 Japan Type 2 Diabetes Consumption Forecast (2022-2028)
-
13.4.3 India Type 2 Diabetes Consumption Forecast (2022-2028)
-
13.4.4 South Korea Type 2 Diabetes Consumption Forecast (2022-2028)
-
13.4.5 Pakistan Type 2 Diabetes Consumption Forecast (2022-2028)
-
13.4.6 Bangladesh Type 2 Diabetes Consumption Forecast (2022-2028)
-
13.4.7 Indonesia Type 2 Diabetes Consumption Forecast (2022-2028)
-
13.4.8 Thailand Type 2 Diabetes Consumption Forecast (2022-2028)
-
13.4.9 Singapore Type 2 Diabetes Consumption Forecast (2022-2028)
-
13.4.10 Malaysia Type 2 Diabetes Consumption Forecast (2022-2028)
-
13.4.11 Philippines Type 2 Diabetes Consumption Forecast (2022-2028)
-
13.4.12 Vietnam Type 2 Diabetes Consumption Forecast (2022-2028)
-
13.5 South America Consumption Analysis
-
13.5.1 Brazil Type 2 Diabetes Consumption Forecast (2022-2028)
-
13.5.2 Colombia Type 2 Diabetes Consumption Forecast (2022-2028)
-
13.5.3 Chile Type 2 Diabetes Consumption Forecast (2022-2028)
-
13.5.4 Argentina Type 2 Diabetes Consumption Forecast (2022-2028)
-
13.5.5 Venezuela Type 2 Diabetes Consumption Forecast (2022-2028)
-
13.5.6 Peru Type 2 Diabetes Consumption Forecast (2022-2028)
-
13.5.7 Puerto Rico Type 2 Diabetes Consumption Forecast (2022-2028)
-
13.5.8 Ecuador Type 2 Diabetes Consumption Forecast (2022-2028)
-
13.6 GCC Consumption Analysis
-
13.6.1 Bahrain Type 2 Diabetes Consumption Forecast (2022-2028)
-
13.6.2 Kuwait Type 2 Diabetes Consumption Forecast (2022-2028)
-
13.6.3 Oman Type 2 Diabetes Consumption Forecast (2022-2028)
-
13.6.4 Qatar Type 2 Diabetes Consumption Forecast (2022-2028)
-
13.6.5 Saudi Arabia Type 2 Diabetes Consumption Forecast (2022-2028)
-
13.6.6 United Arab Emirates Type 2 Diabetes Consumption Forecast (2022-2028)
-
13.7 Africa Consumption Analysis
-
13.7.1 Nigeria Type 2 Diabetes Consumption Forecast (2022-2028)
-
13.7.2 South Africa Type 2 Diabetes Consumption Forecast (2022-2028)
-
13.7.3 Egypt Type 2 Diabetes Consumption Forecast (2022-2028)
-
13.7.4 Algeria Type 2 Diabetes Consumption Forecast (2022-2028)
-
13.8 Oceania Consumption Analysis
-
13.8.1 Australia Type 2 Diabetes Consumption Forecast (2022-2028)
-
13.8.2 New Zealand Type 2 Diabetes Consumption Forecast (2022-2028)
14 Conclusions
The List of Tables and Figures
-
Table Definition of Type 2 Diabetes
-
Figure of Type 2 Diabetes Picture
-
Table Global Type 2 Diabetes Import by Region (Top 10 Countries) (2017-2028)
-
Table Global Type 2 Diabetes Export by Region (Top 10 Countries) (2017-2028)
-
Figure Global Insulins Consumption and Growth Rate (2017-2022)
-
Figure Global DPP-4 Inhibitors Consumption and Growth Rate (2017-2022)
-
Figure Global GLP-1 Receptor Agonists Consumption and Growth Rate (2017-2022)
-
Figure Global SGLT-2 Inhibitors Consumption and Growth Rate (2017-2022)
-
Figure Global Drugstore Consumption and Growth Rate (2017-2022)
-
Figure Global Hospital Consumption and Growth Rate (2017-2022)
-
Figure Global Others Consumption and Growth Rate (2017-2022)
-
Figure Global Type 2 Diabetes Consumption by Country (2017-2022)
-
Table North America Type 2 Diabetes Consumption by Country (2017-2022)
-
Figure United States Type 2 Diabetes Consumption and Growth Rate (2017-2022)
-
Figure Canada Type 2 Diabetes Consumption and Growth Rate (2017-2022)
-
Figure Mexico Type 2 Diabetes Consumption and Growth Rate (2017-2022)
-
Table Europe Type 2 Diabetes Consumption by Country (2017-2022)
-
Figure Germany Type 2 Diabetes Consumption and Growth Rate (2017-2022)
-
Figure UK Type 2 Diabetes Consumption and Growth Rate (2017-2022)
-
Figure Spain Type 2 Diabetes Consumption and Growth Rate (2017-2022)
-
Figure Belgium Type 2 Diabetes Consumption and Growth Rate (2017-2022)
-
Figure France Type 2 Diabetes Consumption and Growth Rate (2017-2022)
-
Figure Italy Type 2 Diabetes Consumption and Growth Rate (2017-2022)
-
Figure Denmark Type 2 Diabetes Consumption and Growth Rate (2017-2022)
-
Figure Finland Type 2 Diabetes Consumption and Growth Rate (2017-2022)
-
Figure Norway Type 2 Diabetes Consumption and Growth Rate (2017-2022)
-
Figure Sweden Type 2 Diabetes Consumption and Growth Rate (2017-2022)
-
Figure Poland Type 2 Diabetes Consumption and Growth Rate (2017-2022)
-
Figure Russia Type 2 Diabetes Consumption and Growth Rate (2017-2022)
-
Figure Turkey Type 2 Diabetes Consumption and Growth Rate (2017-2022)
-
Table APAC Type 2 Diabetes Consumption by Country (2017-2022)
-
Figure China Type 2 Diabetes Consumption and Growth Rate (2017-2022)
-
Figure Japan Type 2 Diabetes Consumption and Growth Rate (2017-2022)
-
Figure India Type 2 Diabetes Consumption and Growth Rate (2017-2022)
-
Figure South Korea Type 2 Diabetes Consumption and Growth Rate (2017-2022)
-
Figure Pakistan Type 2 Diabetes Consumption and Growth Rate (2017-2022)
-
Figure Bangladesh Type 2 Diabetes Consumption and Growth Rate (2017-2022)
-
Figure Indonesia Type 2 Diabetes Consumption and Growth Rate (2017-2022)
-
Figure Thailand Type 2 Diabetes Consumption and Growth Rate (2017-2022)
-
Figure Singapore Type 2 Diabetes Consumption and Growth Rate (2017-2022)
-
Figure Malaysia Type 2 Diabetes Consumption and Growth Rate (2017-2022)
-
Figure Philippines Type 2 Diabetes Consumption and Growth Rate (2017-2022)
-
Figure Vietnam Type 2 Diabetes Consumption and Growth Rate (2017-2022)
-
Table South America Type 2 Diabetes Consumption by Country (2017-2022)
-
Figure Brazil Type 2 Diabetes Consumption and Growth Rate (2017-2022)
-
Figure Colombia Type 2 Diabetes Consumption and Growth Rate (2017-2022)
-
Figure Chile Type 2 Diabetes Consumption and Growth Rate (2017-2022)
-
Figure Argentina Type 2 Diabetes Consumption and Growth Rate (2017-2022)
-
Figure Venezuela Type 2 Diabetes Consumption and Growth Rate (2017-2022)
-
Figure Peru Type 2 Diabetes Consumption and Growth Rate (2017-2022)
-
Figure Puerto Rico Type 2 Diabetes Consumption and Growth Rate (2017-2022)
-
Figure Ecuador Type 2 Diabetes Consumption and Growth Rate (2017-2022)
-
Table GCC Type 2 Diabetes Consumption by Country (2017-2022)
-
Figure Bahrain Type 2 Diabetes Consumption and Growth Rate (2017-2022)
-
Figure Kuwait Type 2 Diabetes Consumption and Growth Rate (2017-2022)
-
Figure Oman Type 2 Diabetes Consumption and Growth Rate (2017-2022)
-
Figure Qatar Type 2 Diabetes Consumption and Growth Rate (2017-2022)
-
Figure Saudi Arabia Type 2 Diabetes Consumption and Growth Rate (2017-2022)
-
Figure United Arab Emirates Type 2 Diabetes Consumption and Growth Rate (2017-2022)
-
Table Africa Type 2 Diabetes Consumption by Country (2017-2022)
-
Figure Nigeria Type 2 Diabetes Consumption and Growth Rate (2017-2022)
-
Figure South Africa Type 2 Diabetes Consumption and Growth Rate (2017-2022)
-
Figure Egypt Type 2 Diabetes Consumption and Growth Rate (2017-2022)
-
Figure Algeria Type 2 Diabetes Consumption and Growth Rate (2017-2022)
-
Table Oceania Type 2 Diabetes Consumption by Country (2017-2022)
-
Figure Australia Type 2 Diabetes Consumption and Growth Rate (2017-2022)
-
Figure New Zealand Type 2 Diabetes Consumption and Growth Rate (2017-2022)
-
Table AstraZeneca Company Details
-
Table AstraZeneca Type 2 Diabetes Sales, Price, Value and Gross Profit (2017-2022)
-
Table AstraZeneca Type 2 Diabetes Main Business and Markets Served
-
Table AstraZeneca Type 2 Diabetes Product Portfolio
-
Table Daiichi Sankyo Company Details
-
Table Daiichi Sankyo Type 2 Diabetes Sales, Price, Value and Gross Profit (2017-2022)
-
Table Daiichi Sankyo Type 2 Diabetes Main Business and Markets Served
-
Table Daiichi Sankyo Type 2 Diabetes Product Portfolio
-
Table Sanofi Company Details
-
Table Sanofi Type 2 Diabetes Sales, Price, Value and Gross Profit (2017-2022)
-
Table Sanofi Type 2 Diabetes Main Business and Markets Served
-
Table Sanofi Type 2 Diabetes Product Portfolio
-
Table Eli Lily Company Details
-
Table Eli Lily Type 2 Diabetes Sales, Price, Value and Gross Profit (2017-2022)
-
Table Eli Lily Type 2 Diabetes Main Business and Markets Served
-
Table Eli Lily Type 2 Diabetes Product Portfolio
-
Table Merck Company Details
-
Table Merck Type 2 Diabetes Sales, Price, Value and Gross Profit (2017-2022)
-
Table Merck Type 2 Diabetes Main Business and Markets Served
-
Table Merck Type 2 Diabetes Product Portfolio
-
Table Biocon Company Details
-
Table Biocon Type 2 Diabetes Sales, Price, Value and Gross Profit (2017-2022)
-
Table Biocon Type 2 Diabetes Main Business and Markets Served
-
Table Biocon Type 2 Diabetes Product Portfolio
-
Table Novo Nordisk Company Details
-
Table Novo Nordisk Type 2 Diabetes Sales, Price, Value and Gross Profit (2017-2022)
-
Table Novo Nordisk Type 2 Diabetes Main Business and Markets Served
-
Table Novo Nordisk Type 2 Diabetes Product Portfolio
-
Table Boehringer Ingelheim Company Details
-
Table Boehringer Ingelheim Type 2 Diabetes Sales, Price, Value and Gross Profit (2017-2022)
-
Table Boehringer Ingelheim Type 2 Diabetes Main Business and Markets Served
-
Table Boehringer Ingelheim Type 2 Diabetes Product Portfolio
-
Table Astellas Pharma Company Details
-
Table Astellas Pharma Type 2 Diabetes Sales, Price, Value and Gross Profit (2017-2022)
-
Table Astellas Pharma Type 2 Diabetes Main Business and Markets Served
-
Table Astellas Pharma Type 2 Diabetes Product Portfolio
-
Figure Global Insulins Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global DPP-4 Inhibitors Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global GLP-1 Receptor Agonists Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global SGLT-2 Inhibitors Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Drugstore Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Hospital Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Others Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Type 2 Diabetes Consumption Forecast by Country (2022-2028)
-
Table North America Type 2 Diabetes Consumption Forecast by Country (2022-2028)
-
Figure United States Type 2 Diabetes Consumption Forecast and Growth Rate (2022-2028)
-
Figure Canada Type 2 Diabetes Consumption Forecast and Growth Rate (2022-2028)
-
Figure Mexico Type 2 Diabetes Consumption Forecast and Growth Rate (2022-2028)
-
Table Europe Type 2 Diabetes Consumption Forecast by Country (2022-2028)
-
Figure Germany Type 2 Diabetes Consumption Forecast and Growth Rate (2022-2028)
-
Figure UK Type 2 Diabetes Consumption Forecast and Growth Rate (2022-2028)
-
Figure Spain Type 2 Diabetes Consumption Forecast and Growth Rate (2022-2028)
-
Figure Belgium Type 2 Diabetes Consumption Forecast and Growth Rate (2022-2028)
-
Figure France Type 2 Diabetes Consumption Forecast and Growth Rate (2022-2028)
-
Figure Italy Type 2 Diabetes Consumption Forecast and Growth Rate (2022-2028)
-
Figure Denmark Type 2 Diabetes Consumption Forecast and Growth Rate (2022-2028)
-
Figure Finland Type 2 Diabetes Consumption Forecast and Growth Rate (2022-2028)
-
Figure Norway Type 2 Diabetes Consumption Forecast and Growth Rate (2022-2028)
-
Figure Sweden Type 2 Diabetes Consumption Forecast and Growth Rate (2022-2028)
-
Figure Poland Type 2 Diabetes Consumption Forecast and Growth Rate (2022-2028)
-
Figure Russia Type 2 Diabetes Consumption Forecast and Growth Rate (2022-2028)
-
Figure Turkey Type 2 Diabetes Consumption Forecast and Growth Rate (2022-2028)
-
Table APAC Type 2 Diabetes Consumption Forecast by Country (2022-2028)
-
Figure China Type 2 Diabetes Consumption Forecast and Growth Rate (2022-2028)
-
Figure Japan Type 2 Diabetes Consumption Forecast and Growth Rate (2022-2028)
-
Figure India Type 2 Diabetes Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Korea Type 2 Diabetes Consumption Forecast and Growth Rate (2022-2028)
-
Figure Pakistan Type 2 Diabetes Consumption Forecast and Growth Rate (2022-2028)
-
Figure Bangladesh Type 2 Diabetes Consumption Forecast and Growth Rate (2022-2028)
-
Figure Indonesia Type 2 Diabetes Consumption Forecast and Growth Rate (2022-2028)
-
Figure Thailand Type 2 Diabetes Consumption Forecast and Growth Rate (2022-2028)
-
Figure Singapore Type 2 Diabetes Consumption Forecast and Growth Rate (2022-2028)
-
Figure Malaysia Type 2 Diabetes Consumption Forecast and Growth Rate (2022-2028)
-
Figure Philippines Type 2 Diabetes Consumption Forecast and Growth Rate (2022-2028)
-
Figure Vietnam Type 2 Diabetes Consumption Forecast and Growth Rate (2022-2028)
-
Table South America Type 2 Diabetes Consumption Forecast by Country (2022-2028)
-
Figure Brazil Type 2 Diabetes Consumption Forecast and Growth Rate (2022-2028)
-
Figure Colombia Type 2 Diabetes Consumption Forecast and Growth Rate (2022-2028)
-
Figure Chile Type 2 Diabetes Consumption Forecast and Growth Rate (2022-2028)
-
Figure Argentina Type 2 Diabetes Consumption Forecast and Growth Rate (2022-2028)
-
Figure Venezuela Type 2 Diabetes Consumption Forecast and Growth Rate (2022-2028)
-
Figure Peru Type 2 Diabetes Consumption Forecast and Growth Rate (2022-2028)
-
Figure Puerto Rico Type 2 Diabetes Consumption Forecast and Growth Rate (2022-2028)
-
Figure Ecuador Type 2 Diabetes Consumption Forecast and Growth Rate (2022-2028)
-
Table GCC Type 2 Diabetes Consumption Forecast by Country (2022-2028)
-
Figure Bahrain Type 2 Diabetes Consumption Forecast and Growth Rate (2022-2028)
-
Figure Kuwait Type 2 Diabetes Consumption Forecast and Growth Rate (2022-2028)
-
Figure Oman Type 2 Diabetes Consumption Forecast and Growth Rate (2022-2028)
-
Figure Qatar Type 2 Diabetes Consumption Forecast and Growth Rate (2022-2028)
-
Figure Saudi Arabia Type 2 Diabetes Consumption Forecast and Growth Rate (2022-2028)
-
Figure United Arab Emirates Type 2 Diabetes Consumption Forecast and Growth Rate (2022-2028)
-
Table Africa Type 2 Diabetes Consumption Forecast by Country (2022-2028)
-
Figure Nigeria Type 2 Diabetes Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Africa Type 2 Diabetes Consumption Forecast and Growth Rate (2022-2028)
-
Figure Egypt Type 2 Diabetes Consumption Forecast and Growth Rate (2022-2028)
-
Figure Algeria Type 2 Diabetes Consumption Forecast and Growth Rate (2022-2028)
-
Table Oceania Type 2 Diabetes Consumption Forecast by Country (2022-2028)
-
Figure Australia Type 2 Diabetes Consumption Forecast and Growth Rate (2022-2028)
-
Figure New Zealand Type 2 Diabetes Consumption Forecast and Growth Rate (2022-2028)
-
